General MedicationsORALGeneric
VASCOR
BEPRIDIL HYDROCHLORIDE
Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary
Approval overview VASCOR is listed in Drugs@FDA under application 019002 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient BEPRIDIL HYDROCHLORIDE Form and strength TABLET;ORAL - 200MG Sponsor JOHNSON AND JOHNSON Submission history Latest submission status date: 2001-02-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview VASCOR is listed in Drugs@FDA under application 019002 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient BEPRIDIL HYDROCHLORIDE Form and strength TABLET;ORAL - 200MG Sponsor JOHNSON AND JOHNSON Submission history Latest submission status date: 2001-02-06 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.